Novo Nordisk Weight-loss Drug Shows Liver Benefits in Mouse Study (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Reuters ...
New targeted therapies reshape biliary tract cancer care, highlighting FGFR2/IDH1, HER2 and KRAS options plus smarter ...
The FDA has granted orphan drug Designation to tovecimig (CTX-009) for the treatment of patients with biliary tract cancer ...
A new targeted treatment for a rare and aggressive form of bile duct cancer has been recommended by NICE for routine use on the NHS in England, giving people more time with better quality of life.
A new targeted treatment for a rare and aggressive bile duct cancer has been approved by NICE, offering patients longer ...
With awareness still lacking doctors stress the need to be more vigilant. Dr. Vibhor Borkar says recognizing early signs and ...
In the past decade, immune checkpoint inhibitors (ICIs) have dramatically changed cancer treatment, significantly improving ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but can cause immune‑mediated hepatotoxicity (IMH), a potentially serious ...
Jazz Pharma's Ziihera and Eli Lilly's Jaypirca, respectively – have been recommended by reimbursement agency NICE for NHS use ...
A study of more than 10 million siblings suggests that firstborns are more likely to be autistic and have allergies, while ...
NHS approves new treatment for aggressive cancer that could triple life expectancy - Also known as Ziihera, the antibody ...
Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results